WiseGuyReports has announced the addition of a new intelligence report, titled “Newborn Screening – Global Market Outlook (2017-2023)”.
According to research report, the Global Newborn Screening Market is accounted from $599.77 million in 2016 to reach $1395.65 million by 2023 with a CAGR of 12.7%. Increasing chromosomal abnormalities in infants, growing awareness in urbanized nations and rising panel of newborn infections are some of the key factors fueling the market growth. However, lack of specialized infrastructure and socio- economic barriers in emerging countries are hindering the growth of the market. Government initiatives and screening of aging disorder provides ample opportunities for the market growth.
Newborn screening is the practice of testing all babies in their starting stage of life for certain disorders and situations that can delay their normal growth. This testing is necessary in each state and is normally performed before the baby leaves the hospital. The circumstances included in newborn screening can cause severe health problems starting in infancy or childhood. Early detection and treatment can help out to avoid intellectual and physical disabilities and life threatening illnesses.
By test type, Dried Blood Spot (DBS) testing is a simple method of collecting, shipping and storing blood samples. DBS sampling has been used for clinical and pre-clinical pharmacokinetic studies, taking advantage of smaller sampling needs and simplified sample collection and handling. DBS sampling has also been used for disease surveillance in emerging nations.
North America captured the largest market share owing to the increasing awareness and increasing prevalence of cardiovascular disorders. Asia-Pacific region is expected to grow at a faster rate during the forecast period due to rising fertility rates and newborn death rates in the region.
Some of the key players in Newborn Screening market include Perkinelmer, Inc., Natus Medical Incorporated, Agilent Technologies Inc., Covidien PLC, Trivitron Healthcare, AB Sciex LLC, Masimo Corporation, GE Healthcare, Waters Corporation, Bio-Rad Laboratories, Inc., Bio Tek Instruments, Inc., Cardinal Health, Inc., Medtronic Plc, Thermo Fisher Scientific, Inc., Zen Tech S.A. and Neogen Labs Pvt. Ltd.
- DNA-Based Assays
- Pulse Oximetry Screening Technology
- Tandem Mass Spectrometry (TMS)
- Immunoassays and Enzymatic Assays
- Hearing Screen Technology
Product Types Covered:
- Reagents and Assay Kits
Test Types Covered:
- Hearing Screen Test
- Dry Blood Spot Test
- Critical Congenital Heart Diseases (CCHD) Test
- Ambulatory Care
- Nursing Homes
- Hearing Disability
- Blood Spot Disease
- Thyroid Disorder
- Sickle Cells Disease
- Maple Syrup Disease
- Critical Congenital Cardiac Disease
- North America
o Rest of Europe
- Asia Pacific
o New Zealand
o South Korea
o Rest of Asia Pacific
- South America
o Rest of South America
- Middle East & Africa
o Saudi Arabia
o South Africa
o Rest of Middle East & Africa
What our report offers:
– Market share assessments for the regional and country level segments
– Market share analysis of the top industry players
– Strategic recommendations for the new entrants
– Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
– Strategic recommendations in key business segments based on the market estimations
– Competitive landscaping mapping the key common trends
– Company profiling with detailed strategies, financials, and recent developments
– Supply chain trends mapping the latest technological advancements
Table of Content
1 Executive Summary
3 Market Trend Analysis
4 Porters Five Force Analysis
5 Global Newborn Screening Market, By Technology
6 Global Newborn Screening Market, By Product Type
7 Global Newborn Screening Market, By Test Type
8 Global Newborn Screening Market, By End-User
9 Global Newborn Screening Market, By Disease
10 Global Newborn Screening Market, By Geography
11 Key Developments
12 Company Profiling
12.1 Perkinelmer, Inc.
12.2 Natus Medical Incorporated
12.3 Agilent Technologies Inc.
12.4 Covidien PLC
12.5 Trivitron Healthcare
12.6 AB Sciex LLC
12.7 Masimo Corporation
12.8 GE Healthcare
12.9 Waters Corporation
12.10 Bio-Rad Laboratories, Inc.
12.11 Bio Tek Instruments, Inc.
12.12 Cardinal Health, Inc.
12.13 Medtronic Plc
12.14 Thermo Fisher Scientific, Inc.
12.15 Zen Tech S.A.
12.16 Neogen Labs Pvt. Ltd.
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)